ULCERATIVE COLITIS CHRONIC
Clinical trials for ULCERATIVE COLITIS CHRONIC explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ulcerative colitis: drug combo trial launches
Disease control Recruiting nowThis study tests two drugs, eltrekibart and mirikizumab, alone or together, in 140 adults with moderate-to-severe ulcerative colitis. The goal is to see if they can safely help patients achieve remission. Participants must have tried other treatments without success.
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 02:44 UTC
-
New hope for kids with IBD: Long-Term drug trial launches
Disease control Recruiting nowThis study looks at how well and how safely the drug mirikizumab works over a long period (about 3 years) in children and teenagers with moderate-to-severe ulcerative colitis or Crohn's disease. Participants must have already been in a previous mirikizumab study and may continue …
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Probiotic pill shows promise for gut inflammation in early trial
Disease control Recruiting nowThis early-stage study is testing a probiotic pill called R-3750 in 36 adults with mild to moderate ulcerative colitis. The main goal is to see if the pill is safe and tolerable. Participants will take the probiotic by mouth and report their symptoms, while researchers check bloo…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated May 14, 2026 12:02 UTC